Evidence map›Paper›PMID 41959291›Full record

ArticlebioRxiv : the preprint server for biology2026

A Tissue Virus Microenvironment with Activated Stress Responses Underlies Durable SIV Persistence.

Thomas J Hope, Eliana U Crentsil, Muhammad S Arif, Yanique Thomas, Ellen Zhang, Christopher T Thuruthiyil, Ryan V Moriarty, Flora Engelmann, Sean C Pascoe, Jenna M Hasson and 14 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Thomas J HopeDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.ORCID 0000-0001-7183-8319
Eliana U CrentsilDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Muhammad S ArifDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Yanique ThomasDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Ellen ZhangDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Christopher T ThuruthiyilDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Ryan V MoriartyDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Flora EngelmannDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Sean C PascoeDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Jenna M HassonDivision of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Seth H BorrowmanDivision of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Maryam A ShaabanDivision of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Edward J AllenDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Anne MonetteDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Ann M CariasDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Douglas FerrellNew Iberia Research Center, University of Louisiana at Lafayette, New Iberia, Louisiana, USA.
Nawal OuguirtiNew Iberia Research Center, University of Louisiana at Lafayette, New Iberia, Louisiana, USA.
Isabelle ClercDivision of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Judd F HultquistDivision of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Richard T D'AquilaDivision of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Michael D McRavenDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Mariluz AraíngaNew Iberia Research Center, University of Louisiana at Lafayette, New Iberia, Louisiana, USA.
Francois VillingerNew Iberia Research Center, University of Louisiana at Lafayette, New Iberia, Louisiana, USA.
Ramon Lorenzo-RedondoDivision of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Funding

Virology and Immunology Technology CoreP30AI117943 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Sahera Dirajlal-Fargo · 2015 to 2026
$38.4M
CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral DynamicsU54AI170856 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Owen Pornillos · 2022 to 2026
$34.4M
Identification of the Initial Targets of Transmission R37AI094595 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Thomas Hope · 2017 to 2026
$10.0M
Unraveling the Mechanisms of HIV Persistence and ReboundP01AI169600 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Thomas Hope · 2022 to 2026
$9.3M
Pathogenesis of Rebound SIV/HIV Viremia after Antiretrovral TherapyP01AI131346 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2017 to 2021
$8.0M
Role of myeloid cells in CNS and systemic reservoirs and reboundR01MH125778 · NIMH · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Thomas Hope, Ramon Lorenzo-Redondo · 2022 to 2026
$5.1M
Turning off HIV White Noise: Switching from Long-Lived to Short-Lived ReservoirR01AI176599 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Elena Martinelli · 2023 to 2026
$4.7M
Determinants of HIV-1 innate immune sensing and its role in shaping the lymphoid environment.R01AI177265 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI SUMIT K CHANDA, Sunnie Yoh · 2023 to 2026
$3.4M
Deciphering the Role of CPSF6 in HIV InfectionR01AI165236 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HULTQUIST, JUDD F · 2021 to 2025
$2.0M
NIAID NIH HHS P01 AI131346NIAID NIH HHS P01 AI169600NIAID NIH HHS P30 AI117943NIAID NIH HHS R01 AI165236NIAID NIH HHS R01 AI176599NIAID NIH HHS R01 AI177265NIAID NIH HHS R37 AI094595NIAID NIH HHS U54 AI170856NIMH NIH HHS R01 MH125778
6 · The paper itself

Abstract

HIV persistence during suppressive antiretroviral therapy (ART) remains a central barrier to cure, with the majority of reservoirs residing in gut-associated lymphoid tissues (GALT). Here, we define a spatially organized viral microenvironment (VME) that sustains reservoir durability and governs early viral rebound by comparing animals initiating ART early after infection (transient reservoirs) versus late (persistent reservoirs). Using immunoPET/CT-guided sampling of SIV-infected rhesus macaques combined with spatial transcriptomics, we interrogated tissue sites of viral production during the eclipse phase following analytical treatment interruption (ATI). Our results revealed that viral rebound from persistent reservoirs arises from discrete, transcriptionally active foci enriched in the mucosa lining the gut lumen. Eclipse phase persistent reservoirs were characterized by increased proviral burden and a distinct tissue state marked by activation of stress-response, metabolic, mitochondrial, and cell cycle programs coupled to repression of cytoplasmic translation and increased cellular senescence. These features co-occurred with immunosuppressive cellular architectures resembling tertiary lymphoid structures enriched for Treg cells, innate lymphoid cells, and mast cells, regulated by Treg-centered cell-cell interaction networks. In contrast, transient reservoirs displayed enhanced translational and metabolic activity and were embedded within immune-active environments enriched for CD8

Indexed as

analytical treatment interruption (ATI)antiretroviral therapy (ART)gut mucosaHuman Immunodeficiency Virus (HIV)reservoirSimian Immunodeficiency Virus (SIV)spatial transcriptomicsstress responseviral persistence

Identifiers

PMID41959291
PMCPMC13060332

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.